Accounting Policies [Abstract] Accounting Policies [Abstract] Accounts Payable, Current Accounts payable Accounts Receivable, Gross, Current Accounts receivable Accounts Receivable, Net, Current Accounts receivable Accounts Receivable, Net, Current, Total Accrued Liabilities, Current Accrued expenses Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Less accumulated depreciation Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated other comprehensive income Accumulated Other Comprehensive Income (Loss) [Member] Accumulated Other Comprehensive Income [Member] Additional Paid in Capital, Common Stock Additional paid-in capital Additional Paid-in Capital [Member] Additional Paid-in Capital [Member] Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition Stock option expense Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net profit/(loss) to net cash provided by/(used in) operating activities: Allocated Share-based Compensation Expense Stock compensation (expense)/income recognized Allowance for Doubtful Accounts Receivable, Current Allowance for doubtful debts Amendment Flag Amendment Flag Amortization of Financing Costs Financing costs Amount to be paid on first commercial sale. Amount to be Paid on First Commercial Sale Amount to be paid on first commercial sale of non-glucose product Asset Retirement Obligation, Accretion Expense Accretion expense Asset Retirement Obligations, Noncurrent Ending balance Opening balance Asset retirement obligations Asset Retirement Obligations, Policy [Policy Text Block] Asset Retirement Obligations Assets Total assets Assets [Abstract] ASSETS Assets, Current Total current assets Assets, Current [Abstract] Current assets: Assets, Noncurrent Total non-current assets Assets, Noncurrent [Abstract] Non-current assets: Athyrium credit agreement. Athyrium Credit Agreement [Member] Athyrium Credit Agreement [Member] Award Date [Axis] Award Date [Axis] Award Date [Domain] Award Date [Domain] Award Type [Axis] Award Type [Axis] Basis of Accounting [Text Block] Basis of Presentation Basis Of Presentation [Line Items] Basis Of Presentation [Line Items] Basis Of Presentation [Line Items] Basis Of Presentation [Table] Basis Of Presentation [Table] Basis Of Presentation [Table] Cash and Cash Equivalents [Abstract] Cash and Cash Equivalents [Abstract] Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents at end of period Cash and cash equivalents at beginning of period Cash and cash equivalents Cash and Cash Equivalents Disclosure [Text Block] Restricted Cash Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Net decrease in cash and cash equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Cash & Cash Equivalents Class of warrant expiration date. Class Of Warrant Expiration Date Warrants exercise expiration date Class of Warrant or Right, Exercise Price of Warrants or Rights Exercise price of warrants Class of Warrant or Right, Number of Securities Called by Warrants or Rights Number of common stock entitled by issuing warrants Clinical trial expenses. Clinical Trial Expenses Policy [Text Block] Clinical Trial Expenses Collaborative Arrangement Milestone Payment Collaborative Arrangement Milestone Payment Milestone payments paid Collateral. Collateral [Member] Collateral for Facilities [Member] Commitments and Contingencies Commitments and contingencies Commitments and Contingencies, Policy [Policy Text Block] Commitments and Contingencies Common Stock [Member] Ordinary Shares [Member] Common Stock, Par or Stated Value Per Share Common stock, par value Common Stock, Shares Authorized Common stock, shares authorized Common Stock, Shares, Issued Common stock, shares issued Common Stock, Shares, Outstanding Common stock, shares outstanding Common Stock, Value, Issued Common stock, US$0.0001 par value. Authorized 300,000,000 shares; issued and outstanding 175,893,533 shares in 2015 (2014: 175,610,978) Compensation Related Costs, Policy [Policy Text Block] Employee Benefit Costs Comprehensive Income (Loss), Net of Tax, Attributable to Parent Comprehensive loss Comprehensive Income, Policy [Policy Text Block] Total Comprehensive Income Concentration of credit risk and other risks and uncertainties. Concentration Of Credit Risk And Other Risks And Uncertainties Policy [Text Block] Concentration of Credit Risk and Other Risks and Uncertainties Consolidation, Policy [Policy Text Block] Principles of Consolidation Contingent milestone payments on launch of product as per agreement. Contingent Milestone Payments on Launch of Product as per Agreement Milestone payments on launch sign-off for each analyzers as per agreement Cost of Goods and Services Sold Total cost of goods sold & services Cost of Goods and Services Sold [Abstract] Operating costs & expenses Cost of Goods Sold Cost of goods sold Cost of Services Cost of services Credit Facility [Axis] Credit Facility [Axis] Credit Facility [Domain] Credit Facility [Domain] Current Fiscal Year End Date Current Fiscal Year End Date Current year earnings/(loss). Current Year Earnings Loss Current year loss Debt Disclosure [Abstract] Debt Disclosure [Abstract] Debt Disclosure [Text Block] Borrowings Debt Instrument, Face Amount Total amount financed Debt Instrument, Interest Rate, Stated Percentage Interest charged Debt Instrument [Line Items] Debt Instrument [Line Items] Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Debt Instrument, Term Term loan period Debt Issuance Cost Financing costs Deferred Revenue Non-refundable payment Deferred Revenue, Current Deferred revenue Deferred Revenue, Noncurrent Deferred revenue Deferred Revenue, Revenue Recognized Deferred revenue up-front payment recognized Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay Employers contribution to standard defined contribution superannuation funds on behalf of all employees Depreciation, Depletion and Amortization, Nonproduction Depreciation and amortization Derivatives, Policy [Policy Text Block] Derivative Instruments and Hedging Activities Development Expenses Development Expenses Development Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Document And Entity Information [Abstract] Document And Entity Information [Abstract] Document And Entity Information [Abstract] Document Fiscal Period Focus Document Fiscal Period Focus Document Fiscal Year Focus Document Fiscal Year Focus Document Period End Date Document Period End Date Document Type Document Type Earnings Per Share, Basic and Diluted Basic and diluted net loss per share Earnings Per Share, Basic and Diluted [Abstract] Earnings per share Earnings Per Share, Policy [Policy Text Block] Net Loss per Share and Anti-dilutive Securities Effect of Exchange Rate on Cash and Cash Equivalents Effect of exchange rate fluctuations on the balances of cash held in foreign currencies Employee-related Liabilities, Current Employee entitlements provision Employee entitlements provision. Employee Related Liabilities Noncurrent Employee entitlements provision Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized Unrecognized compensation expense related to unvested share-based compensation arrangements Total Employee Stock Option [Member] Employee Stock Option [Member] Entity Central Index Key Entity Central Index Key Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Entity Filer Category Entity Filer Category Entity Registrant Name Entity Registrant Name Equity Component [Domain] Equity Component [Domain] Expected marketing support payment. Expected Marketing Support Payment Total amount of expected marketing support payments Fair Value of Financial Instruments, Policy [Policy Text Block] Fair Value of Financial Instruments Final obligation to reimburse patent fees. Final Obligation To Reimburse Patent Fees Obligation to reimburse patent fees paid by LifeScan thereafter Financial covenant. Financial Covenant [Member] Financial Covenant Pursuant to the Credit Agreement [Member] First obligation to reimburse patent fees. First Obligation To Reimburse Patent Fees First obligation to reimburse patent fees paid by LifeScan Foreign Currency Transaction Gain (Loss), before Tax Foreign currency transaction losses Foreign Currency Transaction Gain (Loss), Unrealized Unrealized foreign exchange losses Foreign Currency Transactions and Translations Policy [Policy Text Block] Foreign Currency General and Administrative Expense General and administrative Goods and services tax. Goods And Services Tax Policy [Text Block] Australian Goods and Services Tax (GST) Grant date one. Grant Date One [Member] Jan-15 [Member] Grant date second. Grant Date Second [Member] Jan-15 [Member] Grant date third. Grant Date Third [Member] Aug-14 [Member] Gross Profit Contribution from products & services Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block] Impairment of Long-Lived Assets Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest Net loss before tax Income Statement [Abstract] Income Statement [Abstract] Income Tax Expense (Benefit) Income tax benefit/(expense) Income Tax, Policy [Policy Text Block] Income Taxes Increase (Decrease) in Accounts Payable and Accrued Liabilities Accounts payable and accrued expenses Increase (Decrease) in Accounts Receivable Accounts receivables Increase (Decrease) in Deferred Revenue Deferred revenue Increase (Decrease) in Employee Related Liabilities Employee entitlements Increase (Decrease) in Inventories Inventory Increase (Decrease) in Operating Capital [Abstract] Change in assets and liabilities: Increase (Decrease) in Prepaid Expense and Other Assets Prepaid expenses and other current assets In Process Research and Development, Policy [Policy Text Block] Collaboration Agreement Interest and other fees included in payments. Interest And Other Fees Included In Payments Less amount representing interest and other fees Interest Expense Interest expense Inventory, Finished Goods, Gross Finished goods Inventory, Net Inventories, net Inventory, Net, Total Inventory, Policy [Policy Text Block] Inventory Inventory, Raw Materials, Gross Raw materials Inventory, Work in Process, Gross Work in progress Investment Income, Interest Interest income Lease, Policy [Policy Text Block] Leased Assets Liabilities Total liabilities Liabilities and Equity Total liabilities and stockholders' equity Liabilities and Equity [Abstract] LIABILITIES AND STOCKHOLDERS' EQUITY Liabilities, Current Total current liabilities Liabilities, Current [Abstract] Current liabilities: Liabilities, Noncurrent Total non-current liabilities Liabilities, Noncurrent [Abstract] Non-current liabilities: License and Services Revenue Agreement of milestone payments Long-term Line of Credit Secured term loan, drawn amount Gross balance of long term debt Line of Credit Facility, Expiration Date Term loan maturity date Line of Credit Facility, Initiation Date Athyrium credit agreement, date Line of credit facility interest rate during default period. Line Of Credit Facility Interest Rate During Default Period Default interest rate under credit agreement Line of Credit Facility, Maximum Borrowing Capacity Secured term loan, amount Line of credit facility non-refundable fees. Line Of Credit Facility Non Refundable Fees Non-refundable fee paid Line of credit facility non-refundable fees percentage. Line Of Credit Facility Non Refundable Fees Percentage Non-refundable fee as percentage of aggregate credit facility Line of Credit Facility, Remaining Borrowing Capacity Secured term loan, undrawn amount Line of credit facility remaining borrowing capacity subject to condition one. Line Of Credit Facility Remaining Borrowing Capacity Subject To Condition One Amount available to be drawn within 30 days, subject to condition one Line of credit facility remaining borrowing capacity subject to condition two. Line Of Credit Facility Remaining Borrowing Capacity Subject To Condition Two Amount available to be drawn within 30 days, subject to condition two Line of credit facility remaining borrowing capacity subject to threshold minimum revenue one. Line Of Credit Facility Remaining Borrowing Capacity Subject To Threshold Minimum Revenue One Quarterly service fee revenues Line of credit facility remaining borrowing capacity subject to threshold minimum revenue two. Line Of Credit Facility Remaining Borrowing Capacity Subject To Threshold Minimum Revenue Two Verio QSF plus coagulation manufacturing revenues Line of Credit Facility, Unused Capacity, Commitment Fee Percentage Percentage of commitment fee paid Long-term Debt Total carrying value Total carrying value Long-term Debt, Current Maturities Less current portion Long term debt including interest and other fees payable. Long Term Debt Including Interest And Other Fees Payable Total minimum payments Long term debt interest accretion. Long Term Debt Interest Accretion Plus interest accretion Long term debt maturities repayments of principal after year four. Long Term Debt Maturities Repayments Of Principal After Year Four Thereafter Long-term Debt, Maturities, Repayments of Principal in Year Four 2018 Long-term Debt, Maturities, Repayments of Principal in Year Three 2017 Long-term Debt, Maturities, Repayments of Principal in Year Two 2016 Long-term Debt, Maturities, Repayments of Principal, Remainder of Fiscal Year 2015 Long-term Debt, Excluding Current Maturities Long term secured loan Total carrying value, non-current portion Lump sum payment period. Lump Sum Payment Period Lump sum payment period for patent fees Marketable Securities, Held-to-maturity Securities, Policy [Policy Text Block] Short-Term Investments (Held-to-maturity) Marketing support payment duration. Marketing Support Payment Duration Duration of payment of marketing support payment on achieving target sales Master Services And Supply Agreement Policy [Text Block] Master Services And Supply Agreement Policy [Text Block] Master Services and Supply Agreement Maximum aggregated turnover to claim research and development tax incentive income Maximum Aggregated Turnover To Claim Research And Development Tax Incentive Income Research and development tax incentive income claim Maximum amount of milestone payments under collaboration agreement to be paid to lenders. :Maximum Amount Of Milestone Payments Under Collaboration Agreement To Be Paid To Lenders Maximum milestone payments to be paid Maximum [Member] Maximum [Member] Maximum number of payments entity may receive. Maximum Number Of Payments Entity May Receive Maximum number of payments entity may receive from Siemens Minimum maturity period of highly liquid investments purchase. Minimum Maturity Period Of Highly Liquid Investments Purchase Minimum maturity period of highly liquid investments purchase Minimum [Member] Minimum [Member] Minimum prepayment of principal amount of term loan. Minimum Prepayment Of Principal Amount Of Term Loan Minimum voluntary repayments Minimum unrestricted cash balance. Minimum Unrestricted Cash Balance Minimum unrestricted cash required Monthly installment payment period. Monthly Installment Payment Period Monthly installment period for patent fees Nature of Operations [Text Block] Organization of the Company Net Cash Provided by (Used in) Financing Activities, Continuing Operations Net cash used in financing activities Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract] Cash flows from financing activities: Net Cash Provided by (Used in) Investing Activities, Continuing Operations Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract] Cash flows from investing activities: Net Cash Provided by (Used in) Operating Activities, Continuing Operations Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract] Cash flows from operating activities: Net Income (Loss) Attributable to Parent Net loss Net loss New Accounting Pronouncements, Policy [Policy Text Block] Recent Accounting Pronouncements Nonoperating Income (Expense) Total other income/(expense) Nonoperating Income (Expense) [Abstract] Other income/(expense) Number of common stock given to each option holder. Number Of Common Stock Given To Each Option Holder Number of common stock given to each option holder Number of milestone payments delivered. Number Of Milestone Payments Delivered Number of milestone payments delivered Operating Costs and Expenses Total operating costs & expenses Operating Costs and Expenses [Abstract] Other operating costs & expenses Operating Income (Loss) Loss from operations Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Other Assets, Current Other current assets Other Assets, Noncurrent Other non-current assets Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Other comprehensive (loss)/gain Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract] Other comprehensive gain, net of tax: Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Net of Tax Reclassification for gain/(loss) realized in net income Other Liabilities, Current Other liability Other Liabilities Disclosure [Abstract] Other Liabilities Disclosure [Abstract] Other Liabilities, Noncurrent Other liability Other Nonoperating Income (Expense) Other Ownership shares held by the related party in the company. Ownership Shares Held By Related Party In Company Decrease in ownership shares held by related party in the company Ownership shares held by second director in company. Ownership Shares Held By Second Director In Company Ownership shares held in Company which has one of our directors Patent and license costs. Patent And License Costs Policy [Text Block] Patent and License Costs Patent Fees Policy [Text Block] Patent Fees Policy [Text Block] Patent Fees Payments of Financing Costs Borrowing costs Payments to Acquire Property, Plant, and Equipment Purchases of property, plant and equipment Percentage of manufacturing initial payment. Percentage Of Manufacturing Initial Payment Percentage of manufacturing initial payment Percentage of milestone payments under collaboration agreement to be paid to lenders. Percentage Of Milestone Payments Under Collaboration Agreement To Be Paid To Lenders Percentage of milestone payments Percentage of premium on closing price of stock. Percentage Of Premium On Closing Price Of Stock Percentage of premium over closing price of common stock PFM cornerstone limited. Pfm Cornerstone Limited [Member] PFM Cornerstone Limited [Member] Preferred Stock, Par or Stated Value Per Share Preferred stock, par value Preferred Stock, Shares Authorized Preferred stock, shares authorized Preferred Stock, Shares Issued Preferred stock, shares issued Preferred Stock, Shares Outstanding Preferred stock, shares outstanding Preferred Stock, Value, Issued Preferred stock, US$0.01 par value. Authorized 1,000,000 shares; issued and outstanding nil in 2015 (2014: nil) Prepaid Expense, Current Prepayments Prepayment premium after second anniversary. Prepayment Premium After Second Anniversary Prepayment premium after second anniversary, percentage Prepayment premium prior to second anniversary. Prepayment Premium Prior To Second Anniversary Prepayment premium prior to second anniversary, percentage Prepayment subject to extraordinary receipts percentage. Prepayment Subject To Extraordinary Receipts Percentage Percentage of prepayment to lenders on net cash proceeds received Proceeds from Collaborators Received a payment Proceeds from Issuance of Long-term Debt Proceeds from borrowings Property, Plant and Equipment, Gross Property, plant and equipment Property, Plant and Equipment, Net Property, plant and equipment-net Property, Plant and Equipment, Policy [Policy Text Block] Property, Plant, and Equipment Property, Plant and Equipment, Useful Life Property plant and equipment useful life Quarterly Financial Information Disclosure [Abstract] Quarterly Financial Information Disclosure [Abstract] Quarterly Financial Information [Text Block] Interim Financial Statements Range [Axis] Range [Axis] Range [Domain] Range [Domain] Receivables, Policy [Policy Text Block] Receivables Related Party [Domain] Related Party [Domain] Related Party Transaction [Line Items] Related Party Transaction [Line Items] Related Party Transactions [Abstract] Related Party Transactions [Abstract] Related Party [Axis] Related Party [Axis] Related Party Transactions Disclosure [Text Block] Related Party Transactions Related party transaction success fee. Related Party Transaction Success Fee Success fee Repayments of Long-term Debt Repayment of borrowings Research and Development Arrangement, Contract to Perform for Others, Type [Axis] Research and Development Arrangement, Contract to Perform for Others, Type [Axis] Research and Development Arrangement, Contract to Perform for Others, Compensation Earned Research and development tax incentive income Research and development tax incentive income Research and Development Arrangement, Contract to Perform for Others [Table Text Block] Schedule of Research and Development Expenses, Net of Research and Development Tax Incentive Income Research and Development Arrangement, Contract to Perform for Others, Type [Domain] Research and Development Arrangement, Contract to Perform for Others, Type [Domain] Research and Development Arrangement [Member] Research and Development Arrangement [Member] Research and Development Expense Research and development Research and development expenses Research and development expenses Research and development expense, net. Research and Development Expense, Net Research and development expenses, net of tax incentive income Research and Development Expense, Policy [Policy Text Block] Research and Development Research and development expenses. Research And Development Expenses Table [Text Block] Research and Development Expenses Research expense. Research Expense Research Restricted Cash and Cash Equivalents Restricted cash Restricted Cash and Cash Equivalents [Axis] Restricted Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Domain] Cash and Cash Equivalents [Domain] Restricted Cash and Cash Equivalents Items [Line Items] Restricted Cash and Cash Equivalents Items [Line Items] Restricted share price. Restricted Share Price Restricted shares of common stock to employees Restricted Stock [Member] Restricted Stock [Member] Restricted stock trading restriction period. Restricted Stock Trading Restriction Period Period of non traded years of existing shares of common stock Retained Earnings (Accumulated Deficit) Accumulated deficit Retained Earnings [Member] Accumulated Deficit [Member] Revenue Recognition, Interest [Policy Text Block] Interest income Revenue Recognition, Milestone Method, Revenue Recognized Revenue recognition, milestone method, revenue recognized Revenue Recognition, Policy [Policy Text Block] Revenue Recognition Revenue recognition research and development revenue. Revenue Recognition Research And Development Revenue Policy [Text Block] Research and development tax incentive income Revenues [Abstract] Revenue Sales and licensing revenues payment. Sales And Licensing Revenues Payment Sales and licensing revenues payments Sales Revenue, Goods, Net Revenue from products Revenue, Net Total revenue Sales Revenue, Services, Net Revenue from services Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block] Summary of Receivables Schedule of Asset Retirement Obligations [Table Text Block] Asset Retirement Obligations Schedule of Inventory, Current [Table Text Block] Inventory, Net Schedule of Maturities of Long-term Debt [Table Text Block] Future Maturities, Interest and Other Payments under Company's Long Term Secured Loan Pursuant to Credit Agreement Schedule of Related Party Transactions, by Related Party [Table] Schedule of Related Party Transactions, by Related Party [Table] Schedule of Restricted Cash and Cash Equivalents [Table] Schedule of Restricted Cash and Cash Equivalents [Table] Schedule of Restricted Cash and Cash Equivalents [Table Text Block] Restricted Cash Maintained by the Company in the Form of Term Deposits Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block] Restricted Stock Awards Activity Schedule of Share-based Compensation, Restricted Stock Units Award Activity [Table Text Block] Restricted Shares Issued Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] Stock Option Activity Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Assumptions for Option Grants Issued Schedule of Unrecognized Compensation Cost, Nonvested Awards [Table Text Block] Unrecognized Compensation Expense Related to Unvested Share-Based Compensation Arrangements Expected to be Recognized Share-based Compensation Share based payments expense Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Options granted under our share option plan Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Number of shares, Granted Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Weighted average issue price, Granted Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Number of shares, Ending Balance Number of shares, Beginning Balance Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Weighted average issue price, Ending Balance Weighted average issue price, Beginning Balance Share based compensation arrangement by share based payment award equity instruments other than options release in period. Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Release In Period Number of shares, Release of restricted shares Share based compensation arrangement by share based payment award equity instruments other than options release in period weighted average grant date fair value. Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Release In Period Weighted Average Grant Date Fair Value Weighted average issue price, Release of restricted shares Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price Exercise Price Exercise price of awarded stock options Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Expected Life (years) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate Volatility Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Risk Free Interest Rate Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Number of options exercisable Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period Stock Options, Number of shares, Lapsed Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Stock Options, Number of shares, Granted Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Fair Value of Option Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Aggregate intrinsic value for all options outstanding Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Stock Options, Outstanding Number of shares, Ending Balance Stock Options, Outstanding Number of shares, Beginning Balance Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Stock Options, Weighted average exercise price, Ending Balance Stock Options, Weighted average exercise price, Beginning Balance Equity Award [Domain] Equity Award [Domain] Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Stock Options, Weighted average exercise price, Exercised Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Stock Options, Weighted average exercise price, Lapsed Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Stock Options, Weighted average exercise price, Granted Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block] Stock-based Compensation Share Price Share Price at Grant Date Shares, Outstanding Ending Balance, Shares Beginning Balance, Shares Short-term Debt Borrowings Short term investment maturity period maximum. Short Term Investment Maturity Period Maximum Short-term investments maturity period, maximum Short term investment maturity period minimum. Short Term Investment Maturity Period Minimum Short-term investments maturity period, minimum Significant Accounting Policies [Text Block] Summary of Significant Accounting Policies SpeeDx. Speedx [Member] SpeeDx [Member] Equity Components [Axis] Equity Components [Axis] Statement [Line Items] Statement [Line Items] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Statement [Table] Statement [Table] Stockholders' Equity Attributable to Parent Ending Balance Beginning Balance Total stockholders' equity Stockholders' Equity Attributable to Parent [Abstract] Stockholders' equity: Stock Issued During Period, Shares, Restricted Stock Award, Gross Number of Restricted Shares Issued Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Exercise of stock options issued to employees, Shares Stock Options, Number of shares, Exercised Stock Issued During Period, Value, Restricted Stock Award, Gross Market Value of Restricted Shares Issued Stock Issued During Period, Value, Stock Options Exercised Exercise of stock options issued to employees Sufficient cash and cash equivalents to fund operations. Sufficient Cash And Cash Equivalents To Fund Operations Sufficient cash and cash equivalents to fund our operations Summary Of Significant Accounting Policies [Line Items] Summary Of Significant Accounting Policies [Line Items] Summary Of Significant Accounting Policies [Line Items] Summary Of Significant Accounting Policies [Table] Summary Of Significant Accounting Policies [Table] Summary Of Significant Accounting Policies [Table] Target strips for marketing support payment. Target Strips For Marketing Support Payment Target strips to be sold for payment of marketing support payment Technology Services Revenue Consulting fees Text Block [Abstract] Text Block [Abstract] Trading Symbol Trading Symbol Unrecognized compensation expense related to unvested share based compensation arrangements expected to be recognized in year three. Unrecognized Compensation Expense Related To Unvested Share Based Compensation Arrangements Expected To Be Recognized In Year Three 2017 Unrecognized compensation expense related to unvested share based compensation arrangements expected to be recognized in year two. Unrecognized Compensation Expense Related To Unvested Share Based Compensation Arrangements Expected To Be Recognized In Year Two 2016 Unrecognized compensation expense related to unvested share based compensation arrangements expected to be recognized within one year. Unrecognized Compensation Expense Related To Unvested Share Based Compensation Arrangements Expected To Be Recognized Within One Year 2015 Use of Estimates, Policy [Policy Text Block] Use of Estimates Warrants disclosure. Warrants Disclosure [Text Block] Warrants Warrants exercisable period. Warrants Exercisable Period Warrants exercisable period Warrants in multiples of shares minimum. Warrants Exercise in Multiples of Shares Minimum Warrants exercise in multiples of shares, minimum Warrants fair value disclosure. Warrants Fair Value Disclosure Fair value included in long term debt carrying value Less fair value of warrants recorded within loan Zero priced employee options. Zero Priced Employee Options [Member] Zero Priced Employee Options [Member]